Influence of Respiratory Muscle Training in Elderly Hypertensive Women With Respiratory Muscle Weakness

December 4, 2012 updated by: Patra-cia Angelica de Miranda Silva Nogueira, Universidade Federal do Rio Grande do Norte
This study aims to evaluate pulmonary function and respiratory muscle strength in a group of elderly women with hypertension before and after a respiratory muscle training.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

It is a respiratory muscle training using the Threshold for 5 weeks, with a load of 30% of maximal inspiratory pressure obtained in manometer for 30 minutes daily. Furthermore, the assessment includes: test 6-minute walk, the quality of life questionnaire, MINICHAL, the IPAQ short version, manometer and spirometry.

Study Type

Interventional

Enrollment (Actual)

4

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande do Norte
      • Natal, Rio Grande do Norte, Brazil
        • Universidade Federal do Rio Grande do Norte

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • diagnosis of hypertension controlled by antihypertensive;
  • aged between 60 and 80 years;
  • absence of dementia or cognitive impairments that limit tests;
  • absence of recent myocardial infarction;
  • absence of musculoskeletal limitations that limit tests;
  • availability of time on training days.

Exclusion Criteria:

  • clinical instability;
  • inability to perform any test.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: threshold
Held inspiratory muscle strengthening for 5 weeks with Threshold, charging 30% of maximal inspiratory pressure, 7 days a week, one supervised and unsupervised 6.
The load adjustment was done weekly by a single examiner.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
manovacuometry
Time Frame: 6 weeks
Evaluates indirectly respiratory muscle strength.
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
spirometry
Assesses lung function

Other Outcome Measures

Outcome Measure
Measure Description
quality of life
Assesses the influence of hypertension on the quality of life of target
functional capacity
assesses the cardiopulmonary capacity at sub-maximal
IPAQ
assesses the level of physical activity

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Patrícia Nogueira, Universidade Federal do Rio Grande do Norte

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (Actual)

October 1, 2012

Study Completion (Actual)

November 1, 2012

Study Registration Dates

First Submitted

November 12, 2012

First Submitted That Met QC Criteria

December 4, 2012

First Posted (Estimate)

December 6, 2012

Study Record Updates

Last Update Posted (Estimate)

December 6, 2012

Last Update Submitted That Met QC Criteria

December 4, 2012

Last Verified

December 1, 2012

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypertension

Clinical Trials on Threshold

3
Subscribe